New insights in tumor angiogenesis - Potential for oncological and non-oncological therapies;Neue erkenntnisse in der tumorangiogenese - Potenzial onkologischer und nicht-onkologischer therapien

Klinikarzt

Volumn 39, Issue 1, 2010, Pages 12-17

  Felcht, Moritz ^a   Augustin, Hellmut G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ang 2; Angiogenesis; DII4; NOTCH; PDGF ; TGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; IMATINIB; SORAFENIB; SUNITINIB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CARCINOGENESIS; HUMAN; SHORT SURVEY; SPROUTING;

EID: 77049095865     PISSN: 03412350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1249232     Document Type: Short Survey

References (14)

1. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 18: 1182-1186
2. Ferrara N, Kerbel R. Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974
3. Ellis LM, Hicklin DJ. VEGF-targetet therapy: mechanisms of anti-tumor activity. Nature 2008; 8: 579-591
4. Winkler F, Kozin SV, Tong RT et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004; 6: 553-563
5. Jain RK. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy. Science 2005; 307: 58-62
6. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008; 358: 2039-2049
7. Phng LK, Gerhardt H. Angiogenesis: A team effort coordinated by Notch. Dev Cell 2009; 16: 196-208
8. Adams RH, Diella F, Hennig S et al. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 2001; 104: 57-69
9. Larrivée B, Freitas C, Suchting S et al. Guidance of vascular development: lessons from the nervous system. Circ Res 2009; 104: 428-441
10. Armulik A, Abramsson A, Betsholtz C. Endothelial/ Pericyte Interactions. Circ Res 2005; 97: 512-523
11. Andrae J, Gallini R, Betzholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008; 22: 1276-1312
12. Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10: 165-177
13. Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. J Clin Oncol 2005; 23: 2078-2093
14. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003; 9: 713-725